Acquired hemophilia A: a review of recent data and new therapeutic options
M Franchini, S Vaglio, G Marano, C Mengoli… - …, 2017 - Taylor & Francis
ABSTRACT Objectives: Acquired hemophilia A (AHA) is a rare, but potentially life-
threatening, bleeding disorder caused by an autoantibody against factor VIII that interferes …
threatening, bleeding disorder caused by an autoantibody against factor VIII that interferes …
Acquired haemophilia A: a 2013 update
M Franchini, PM Mannucci - Thrombosis and Haemostasis, 2013 - thieme-connect.com
Acquired haemophilia A (AHA) is a rare but often severe bleeding disorder caused by
autoantibodies against coagulation factor VIII (FVIII). AHA occurs more frequently in the …
autoantibodies against coagulation factor VIII (FVIII). AHA occurs more frequently in the …
[HTML][HTML] Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
Background: Acquired hemophilia A (AHA) is a rare autoimmune disease caused by
autoantibodies against coagulation factor VIII and characterized by spontaneous …
autoantibodies against coagulation factor VIII and characterized by spontaneous …
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
F Baudo, P Collins, A Huth-Kuehne… - Blood, The Journal …, 2012 - ashpublications.org
Acquired hemophilia A is a rare bleeding disorder caused by autoantibodies to coagulation
FVIII. Bleeding episodes at presentation are spontaneous and severe in most cases. Optimal …
FVIII. Bleeding episodes at presentation are spontaneous and severe in most cases. Optimal …
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
Acquired hemophilia A (AHA) is an autoimmune disease caused by an autoantibody to
factor VIII. Patients are at risk of severe and fatal hemorrhage until the inhibitor is eradicated …
factor VIII. Patients are at risk of severe and fatal hemorrhage until the inhibitor is eradicated …
[HTML][HTML] International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
A Huth-Kühne, F Baudo, P Collins, J Ingerslev… - …, 2009 - ncbi.nlm.nih.gov
Acquired hemophilia A (AHA) is a rare bleeding disorder characterized by autoantibodies
directed against circulating coagulation factor (F) VIII. Typically, patients with no prior history …
directed against circulating coagulation factor (F) VIII. Typically, patients with no prior history …
Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
P Collins, F Baudo, A Huth-Kühne, J Ingerslev… - BMC research …, 2010 - Springer
Abstract Background Acquired hemophilia A (AHA) is a rare bleeding disorder caused by an
autoantibody to coagulation factor (F) VIII. It is characterized by soft tissue bleeding in …
autoantibody to coagulation factor (F) VIII. It is characterized by soft tissue bleeding in …
The first case of acquired hemophilia A associated with SARS‐CoV‐2 infection
M Franchini, C Glingani, G De Donno… - American Journal of …, 2020 - ncbi.nlm.nih.gov
To the Editor: Acquired hemophilia A (AHA) is a rare bleeding disorder caused by circulating
autoantibodies directed against clotting factor VIII (FVIII). 1, 2 It involves more frequently …
autoantibodies directed against clotting factor VIII (FVIII). 1, 2 It involves more frequently …
Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO.
PW Collins, E Chalmers, D Hart… - British Journal of …, 2013 - search.ebscohost.com
The article discusses guidelines from the United Kingdom Haemophilia Centre Doctors'
Organisation (UKHCDO) on diagnosis and management of acquired coagulation inhibitors …
Organisation (UKHCDO) on diagnosis and management of acquired coagulation inhibitors …
Acquired hemophilia A: current guidance and experience from clinical practice
AM Pishko, BS Doshi - Journal of blood medicine, 2022 - Taylor & Francis
In acquired hemophilia A (AHA), autoantibodies to coagulation factor VIII (FVIII) neutralize
FVIII activity leading to a potentially severe bleeding diathesis that carries a high rate of …
FVIII activity leading to a potentially severe bleeding diathesis that carries a high rate of …